MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jaad.2021.01.067

Медицинская библиотека · Journal of the American Academy of Dermatology · 2021

The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.

Ju Hyun Jeong, Han Ju Hee, Kim Min-Soo, Lee Si-Hyung, Shin Jung-Won, Choi Mira, Jeong Ki-Heon, Han Tae Young, Choi Chong Won, Lee Hee Jung, Oh Sang Ho, Lee Sang Hoon, Kim Dong Hyun, Shin Jeonghyun, Lee Jong Hee, Kim Sang Seok, Kang Hee Young, Chang Sung Eun, Kim Jeong-Soo, Lee Dong-Youn, Choi Gwang Seong, Suh Dae Hun, Chan Kim You, Park Chul Jong, Kim Ki-Ho, Lee Ai-Young, Chan Park Kyoung, Lee Mu-Hyoung, Bae Jung Min, Korean Society for Vitiligo and the Korean Society for Photomedicine

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Topical calcineurin inhibitors have been used to treat vitiligo, either alone or in combination with phototherapy; however, the long-term safety of these agents remains controversial.

OBJECTIVE

To investigate the risk of lymphoma and skin cancer in vitiligo patients who received topical calcineurin inhibitors or phototherapy.

METHODS

A multicenter retrospective cohort study of 25,694 vitiligo patients who received topical calcineurin inhibitors or phototherapy for 6 weeks or more between 2001 and 2019 was performed. Cumulative doses of topical calcineurin inhibitors and total phototherapy sessions were determined. Outcomes were the development of lymphoma or skin cancer after enrollment, confirmed through chart review and pathology reports.

RESULTS

During 95,203 person-years, 13 cases of lymphoma, 22 of actinic keratosis, 15 of nonmelanoma skin cancer, and 5 of melanoma were observed. The risk of lymphoma and skin cancer was not significantly increased by topical calcineurin inhibitor dose or phototherapy sessions. The interaction between the topical calcineurin inhibitors and phototherapy was not associated with an increased risk of skin cancer.

LIMITATIONS: Retrospective study, individual follow-up duration less than 4 years, and no adjustment for comorbidities and medication history. Not generalizable to other races.

CONCLUSION

The long-term risk of skin cancer or lymphoma was not associated with the use of topical calcineurin inhibitors, phototherapy, and both treatments in combination in patients with vitiligo.

Для цитирования: Ju Hyun Jeong, Han Ju Hee, Kim Min-Soo, Lee Si-Hyung, Shin Jung-Won, Choi Mira, Jeong Ki-Heon, Han Tae Young, Choi Chong Won, Lee Hee Jung, Oh Sang Ho, Lee Sang Hoon, Kim Dong Hyun, Shin Jeonghyun, Lee Jong Hee, Kim Sang Seok, Kang Hee Young, Chang Sung Eun, Kim Jeong-Soo, Lee Dong-Youn, Choi Gwang Seong, Suh Dae Hun, Chan Kim You, Park Chul Jong, Kim Ki-Ho, Lee Ai-Young, Chan Park Kyoung, Lee Mu-Hyoung, Bae Jung Min, Korean Society for Vitiligo and the Korean Society for Photomedicine. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.. Journal of the American Academy of Dermatology. 2021. DOI: 10.1016/j.jaad.2021.01.067.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.